Simtra BioPharma to break ground on $250M expansion
Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
Gov. Eric Holcomb will join executives from New Jersey-based Simtra BioPharma to break ground on the $250 million expansion of the company’s sterile fill/finish manufacturing campus in Bloomington.
The project involves the construction of a 150,000-square-foot building that will house three high-speed, automated fill lines.
Simtra’s campus at 927 South Curry Pike makes pre-filled medical syringes and vials. The new facility, plans for which were first announced in February, will include two syringe fill lines and one vial fill line.
CEO Frances Negron previously said the expansion is the result of a broad increase in demand for injectable manufacturing for a variety of drugs.
“Our customers consider our sites in Halle [Germany] and Bloomington as an extension of their manufacturing network, so we are thrilled to further enhance our capabilities and resources to help them meet their respective goals,” Negron said. “This expansion is the latest in a series of strategic, long-term investments to ensure that Simtra continues to grow with and for our customers.”
The contract development and manufacturing organization plans to add 130 jobs with an average salary of $73,379 as part of the expansion.
The groundbreaking ceremony is scheduled for 2 p.m. Tuesday. Construction is expected to take about two years to complete.